Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases
Home | Video pages | Webcast | GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection
Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases
Cardiorenal Syndrome – Perspectives from Nephrology and Internal Medicine